C. Le Corre

Panobinostat in patients with relapsed/refractory Hodgkin's lymphoma after autologous stem-cell transplantation: results of a phase II study.

P. Zinzani, P. Zinzani, A. Younes, 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

E3N, a French cohort study on cancer risk factors. E3N Group. Etude Epidémiologique auprès de femmes de l'Education Nationale.

F. Clavel-Chapelon, A. Auquier, M. Niravong, 1997, European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation.

Biomarker analysis of pivotal phase II study of oral panobinostat (PAN) in relapsed/refractory Hodgkin lymphoma (HL) patients following autologous stem cell transplant (ASCT).

A. Younes, R. Bugarini, D. Ritchie, 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.